0001628280-23-029142.txt : 20230811
0001628280-23-029142.hdr.sgml : 20230811
20230811184640
ACCESSION NUMBER: 0001628280-23-029142
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230810
FILED AS OF DATE: 20230811
DATE AS OF CHANGE: 20230811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Woo Liyuan
CENTRAL INDEX KEY: 0001499747
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39565
FILM NUMBER: 231165624
MAIL ADDRESS:
STREET 1: 400 VALLEY DRIVE
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Beauty Health Co
CENTRAL INDEX KEY: 0001818093
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 851908962
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2165 SPRING STREET
CITY: LONG BEACH
STATE: CA
ZIP: 90806
BUSINESS PHONE: 800-603-4996
MAIL ADDRESS:
STREET 1: 2165 SPRING STREET
CITY: LONG BEACH
STATE: CA
ZIP: 90806
FORMER COMPANY:
FORMER CONFORMED NAME: Vesper Healthcare Acquisition Corp.
DATE OF NAME CHANGE: 20200714
4
1
wk-form4_1691793990.xml
FORM 4
X0508
4
2023-08-10
1
0001818093
Beauty Health Co
SKIN
0001499747
Woo Liyuan
C/O THE BEAUTY HEALTH COMPANY
2165 SPRING STREET
LONG BEACH
CA
90806
0
0
0
1
Former Chief Financial Officer
0
Stock Options (right to buy)
12.85
2023-08-10
4
D
0
372000
D
2031-05-06
Common Stock
372000
0
D
Stock Options (right to buy)
12.85
2023-08-10
4
A
0
372000
A
2025-08-10
Common Stock
372000
372000
D
The transaction involves an amendment of an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 6, 2021 and represented a grant of 744,000 shares of common stock underlying the option under the issuer's 2021 Incentive Award Plan (the "Plan"). As of Aug 10, 2023, the date of the Reporting Person's separation from the issuer (the "Separation Date"), 372,000 shares underlying the option, had vested (the "Vested Options") and the other 372,000 shares underlying the option, had not vested (the "Unvested Options"). Under the Plan, the Unvested Options were forfeited upon separation and the Vested Options would have to be exercised within 90 days of the Separation Date. However, pursuant to the Reporting Person's separation agreement, as filed in Exhibit 10.2 to the issuer's Current Report on Form 8-K filed on Aug 9, 2023, the expiration date of the Vested Options was extended to Aug 10, 2025.
/s/ Paul Bokota, Attorney-in-Fact for Liyuan Woo
2023-08-11